Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials

The epidermal growth factor receptor (EGFR) family contains four transmembrane tyrosine kinases (EGFR1/ErbB1, Her2/ErbB2, Her3/ErbB3 and Her4/ErbB4) and 13 secreted polypeptide ligands. EGFRs are overexpressed in many solid tumors, including breast, pancreas, head-and-neck, prostate, ovarian, renal,...

Descripción completa

Detalles Bibliográficos
Autores principales: Maennling, Amaia Eleonora, Tur, Mehmet Kemal, Niebert, Marcus, Klockenbring, Torsten, Zeppernick, Felix, Gattenlöhner, Stefan, Meinhold-Heerlein, Ivo, Hussain, Ahmad Fawzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966464/
https://www.ncbi.nlm.nih.gov/pubmed/31756933
http://dx.doi.org/10.3390/cancers11121826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966464/
https://www.ncbi.nlm.nih.gov/pubmed/31756933
http://dx.doi.org/10.3390/cancers11121826

Ejemplares similares